| answer text |
<p>The UK supports HPV vaccination programmes in developing countries through Gavi,
the Vaccine Alliance. As Gavi’s largest donor, the UK was a vocal advocate for inclusion
of the HPV vaccine within its portfolio to help protect the most vulnerable girls
from the leading cause of cervical cancer.</p><p> </p><p>Through Gavi support, 30
developing countries have taken their first steps toward HPV roll out with the aim
of vaccinating 40 million girls by 2020. Affordability and high demand are also important
considerations to enabling HPV vaccination programmes to be introduced. Gavi is helping
overcome these by negotiating price reductions of the HPV vaccine to make it more
affordable for poorer countries and by working with civil society in local communities
to promote the benefits of the vaccine.</p><p> </p><p>The 2017 World Health Assembly
Global Call for Action to eliminate cervical cancer has brought widespread attention
on the importance of HPV. In anticipation of high global demand, the UK has encouraged
Gavi to continue to bring in new vaccine manufacturers to support increased demand
and to prioritise availability for the world’s poorest people.</p>
|
|
